How stem cell therapy for neuropathy works
Stem cell therapy using human umbilical cord tissue-derived mesenchymal stem cells (HUCT-MSCs) reverses degeneration by supplying cells that can transform into nerves, replacing lost or damaged tissue and aiding in cell repair. These stem cells release healing factors like growth factors, cytokines, and exosomes into the surrounding area. This advanced treatment goes beyond pain management by naturally healing and regenerating tissue. In essence, stem cells provide the biological components needed for healthy nerve function. For autoimmune-related nerve damage, they modulate the immune system, shifting it from an inflammatory to an anti-inflammatory state, preventing further nerve damage.
Neuropathy, particularly diabetic neuropathy, can significantly impact blood flow, leading to various complications. While neuropathy itself is nerve damage, the resulting nerve dysfunction can affect the body’s ability to regulate blood flow, and poor circulation can worsen neuropathy symptoms.
To address blood flow, Micro vascular tissue is used in conjunction with stem cells. MVT is a newly FDA approved injectable tissue graft that is used to repair and reconstruct microvascular blood flow in the feet and hands. Increasing blood flow improves the healing environment which has the potential to eliminate pain and improve clinical outcomes.